AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
OREGE.PA

Orege Société Anonyme (OREGE.PA) fair value

Industrials · Waste Management · Euronext Paris · France
€0.29+8.61%
Market cap €15MNext earnings 2025-07-29Updated Oct 22, 2026
Our verdict
Close to our fair value
Price
€0.29
Model fair valueConfidence: low
about €0.30
Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Valued as a pre-revenue company: Analyst consensus.
ACCE opinionOrege Société Anonyme (OREGE.PA)
Fair value
Not available
ACCE price target
€0.20
Rating
Not rated
Horizon
12 months
ACCE price target published on 23 Oct 2026, 01:52 CEST.
Price used: €0.29 at the close on 23 Oct 2026, 17:30 CEST.
Models: Analyst consensus.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
32
out of 100
1-year return
+3.6%
Dividend yield
0.00%

Orege Société Anonyme in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Orege is a French micro-cap (about EUR 13M market cap) in waste management, and the data we have says little about its specific products beyond that sector label, so any deeper look has to start from its filings rather than this screen. Revenue growth of 189.6% sits alongside a gross margin of -82.9% and an operating margin of -191.8%, meaning the company is growing sales while losing money on every euro it sells, which is a scale-or-fail setup rather than a compounder. Return on equity is 0.0%, there are no earnings to put a P/E on, and the stock is not in any index, so liquidity and coverage are thin. The case for a closer look is narrow: if the top-line growth is coming from contracts that can reach positive gross margin at volume, the balance sheet and cash burn become the things to test first. Absent that evidence, this is a name to watch rather than to size.

AI-assisted·How I use AIWritten Oct 23, 2026

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where OREGE.PA's valuation models land
Price
€0.29
Model fair valueConfidence: low
about €0.30
Model
Fair value
Upside
Analyst consensus
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
+20.8%
1 month
+26.1%
3 months
+0.0%
6 months
+7.4%
YTD
-3.3%
1 year
+3.6%

Recommendation history, last 12 months

DateTypeNewPreviousPrice
23 Oct 2026, 01:52 CESTACCE price target€0.20first publication€0.27

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in EUR. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full OREGE.PA page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth64Value16Quality16Momentum31Total32
Valuation
Trailing P/E
no data
Forward P/E
-1.8x
PEG
no data
P/B
60.49x
EV / Revenue
29.8x
Book value/sh
€-1.36
Enterprise value
€89M
Profitability
ROE
0.0%
FCF yield
-118.36%
ROIC
no data
Health and risk
Debt / equity
-1.30
Dividend yield
0.00%
Beta
1.04

Price

+3.6% · 1Y

Ask anything about OREGE.PA

Answered from Orege Société Anonyme fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
ROEbetter than 83% of peers
low -129%0%high 6%
Div yieldbetter than 100% of peers
low 0.0%0.0%high 0.0%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
OREGE.PA Orege Société Anonyme€0.29---0.0%1632
SES.ST Scandinavian Enviro Systems AB (publ)kr 0.15----129.1%3116
QRHC Quest Resource Holding Corporation Common Stock$1.18----50.3%2148
BIOEX.ST Bioextrax AB (publ)kr 2.19----124.0%1414
AXOLOT.ST Axolot Solutions Holding AB (publ)kr 0.25----9.5%2917
GWAV Greenwave Technology Solutions Inc. Common Stock$2.29----56.7%3138
GRI.MC Griñó Ecologic, S.A.€1.45--18.1x5.8%5666

Sector report card

Where OREGE.PA ranks against its sector peers on each metric.

Computing percentiles…